Bing‐Ching Ho
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
-
- RNA Research and Splicing 5
- RNA regulation and disease 5
- Cancer therapeutics and mechanisms 2
-
- Cancer Genomics and Diagnostics 5
- MicroRNA in disease regulation 4
- Co-authors
- Sung‐Liang Yu (21 shared papers)Pan‐Chyr Yang (11 shared papers)Kang‐Yi Su (9 shared papers)Gee‐Chen Chang (4 shared papers)Min‐Liang Kuo (2 shared papers)Ker-Chau Li (2 shared papers)James Chih‐Hsin Yang (1 shared paper)Hsuan‐Yu Chen (1 shared paper)
- Journals
- Oncotarget (3 papers)PLoS ONE (3 papers)Journal of Cellular Biochemistry (2 papers)Scientific Reports (2 papers)Cellular Microbiology (2 papers)
- Partner nations
- TaiwanUnited StatesAustralia
In The Last Decade
Bing‐Ching Ho
29 papers receiving 1.2k citations
Bing‐Ching Ho's Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 420
- Oncology 352
- Pulmonary and Respiratory Medicine 409
- Molecular Biology 627
- Immunology 160
Countries citing papers authored by Bing‐Ching Ho
This map shows the geographic impact of Bing‐Ching Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing‐Ching Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing‐Ching Ho more than expected).
Fields of papers citing papers by Bing‐Ching Ho
This network shows the impact of papers produced by Bing‐Ching Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing‐Ching Ho. The network helps show where Bing‐Ching Ho may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing‐Ching Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer Hit paper breakdown → | 2012 | 429 |
| 2 | 2011 | 128 | |
| 3 | 2014 | 120 | |
| 4 | 2015 | 75 | |
| 5 | 2009 | 46 | |
| 6 | 2013 | 45 | |
| 7 | 2016 | 39 | |
| 8 | 2009 | 36 | |
| 9 | 2014 | 29 | |
| 10 | 2017 | 26 | |
| 11 | 2016 | 25 | |
| 12 | 2016 | 24 | |
| 13 | 2016 | 20 | |
| 14 | 2016 | 18 | |
| 15 | 2019 | 17 | |
| 16 | 2015 | 17 | |
| 17 | 2019 | 16 | |
| 18 | 2019 | 15 | |
| 19 | 2016 | 14 | |
| 20 | 2016 | 13 |
About Bing‐Ching Ho
Bing‐Ching Ho is a scholar working on Molecular Biology, Cancer Research, Oncology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA Research and Splicing (5 papers), RNA regulation and disease (5 papers), Viral Infections and Immunology Research (5 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers), MicroRNA in disease regulation (4 papers), Lung Cancer Research Studies (3 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Cancer Research (420 citations), Oncology (352 citations), Pulmonary and Respiratory Medicine (409 citations), Molecular Biology (627 citations) and Immunology (160 citations). Bing‐Ching Ho has collaborated with scholars based in Taiwan, United States and Australia. Frequent co-authors include Sung‐Liang Yu, Pan‐Chyr Yang, Kang‐Yi Su, Gee‐Chen Chang, Min‐Liang Kuo, Ker-Chau Li, James Chih‐Hsin Yang, Hsuan‐Yu Chen, Jin‐Yuan Shih and Wing‐Kai Chan. Their work appears in journals such as Oncotarget, PLoS ONE, Journal of Cellular Biochemistry, Scientific Reports and Cellular Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.